Skip to content
LexBuild

Advisory Committee on Immunization Practices: Notice of Charter Renewal

---
identifier: "/us/fr/2022-08575"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee on Immunization Practices: Notice of Charter Renewal"
title_number: 0
title_name: "Federal Register"
section_number: "2022-08575"
section_name: "Advisory Committee on Immunization Practices: Notice of Charter Renewal"
positive_law: false
currency: "2022-04-22"
last_updated: "2022-04-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-08575"
document_type: "notice"
publication_date: "2022-04-22"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "87 FR 24168"
fr_volume: 87
fr_action: "Notice of charter renewal."
---

#  Advisory Committee on Immunization Practices: Notice of Charter Renewal

**AGENCY:**

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION:**

Notice of charter renewal.

**SUMMARY:**

This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through April 1, 2024.

**FOR FURTHER INFORMATION CONTACT:**

Melinda Wharton, M.D., M.P.H., Designated Federal Officer, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, Georgia 30329-4027, telephone (404) 639-8755, or fax (404) 471-8347.

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.